Discover 566 paid clinical trials in Norman, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 566
Designing Effective Alcohol Health Warnings: An Experimental Study With Adults in the U.S.
for
Risk Perceptions, Decision Making, Alcohol
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: Female
Age: 18 - 65
Code: NCT07812545
Recruiting
Connect2Care: Prostate Cancer Education and Screenings for African American Men
for
Prostate Cancer, Health Behavior
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: Male
Age: 45 - 69
Code: NCT07055165
Recruiting
A Culturally Tailored Smartphone Application for African American Smokers
for
Smoking Cessation
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18+
Code: NCT05188287
Recruiting
Attitudes and Perceptions Attitudes and Smoking Perceptions in the Real Environment -II
for
Cigarillo Flavor
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18 - 34
Code: NCT06668350
Recruiting
Impact of Semaglutide on Tobacco Use and Related Health Behaviors
for
Tobacco Use
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18 - 65
Code: NCT06986993
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Letrozole in Uterine Leiomyosarcoma
for
Uterine Leiomyosarcoma
Location: Oklahoma City OK, Shreveport LA, Highlands Ranch CO,
Sponsor: GOG Foundation
Sex: Female
Age: 18+
Code: NCT05649956
Phase 2, Recruiting
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Oklahoma City OK, Houston TX, St Louis MO, Nashville TN,
Sponsor: Fate Therapeutics
Sex: All
Age: 18+
Code: NCT06241456
Phase 1, Recruiting
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
for
Endometrial Cancer
Location: Oklahoma City OK
Sponsor: Alliance Foundation Trials, LLC.
Sex: Female
Age: 18+
Code: NCT04486352
Phase 1, Phase 2, Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Oklahoma City OK, Fort Worth TX, St Louis MO,
Sponsor: TORL Biotherapeutics, LLC
Sex: Female
Age: 18+
Code: NCT06690775
Phase 2, Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Location: Oklahoma City OK, Birmingham AL, Ann Arbor MI,
Sponsor: Oncotartis, Inc.
Sex: All
Age: 18+
Code: NCT03921879
Phase 1, Recruiting
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
for
Ovarian Cancer, Solid Tumor
Location: Oklahoma City OK, Houston TX, San Antonio TX, Denver CO,
Sponsor: OnCusp Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06234423
Phase 1, Recruiting
A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
for
Endometrioid Cancer, Mucinous Ovarian Cancer,
Location: Oklahoma City OK, Albuquerque NM, New Orleans LA,
Sponsor: University of Oklahoma
Sex: Female
Age: 18 - 70+
Code: NCT05512208
Phase 2, Recruiting
Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Oklahoma City OK, Houston TX, Chicago IL, Tampa FL,
Sponsor: Pyxis Oncology, Inc
Sex: All
Age: 18+
Code: NCT06795412
Phase 1, Phase 2, Recruiting
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
for
Androgen Deprivation Therapy, Locally Advanced Prostate Cancer
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: Male
Age: 18+
Code: NCT06130995
Phase 1, Recruiting
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
for
Solid Tumor, Breast Cancer, Pancreatic Cancer, Ovarian Cancer,
Location: Oklahoma City OK, Houston TX, Gilbert AZ, Detroit MI,
Sponsor: Qurgen Inc.
Sex: All
Age: 18+
Code: NCT05989724
Phase 1, Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
for
Carcinoma, Squamous Cell
Location: Oklahoma City OK, Birmingham AL, Lexington KY,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sex: All
Age: 60+
Code: NCT04892173
Phase 3, Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors